Maya H Buch

机构：University of Leeds, Leeds Teaching Hospitals NHS Trust, Manchester Academic Health Science Centre, University of Manchester, National Institute for Health and Care Research, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre · ORCID：0000-0002-8962-5642

发表论文 498 篇 · 总被引 25819 次 · h-index 70

代表论文

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update (2026 · Annals of the Rheumatic Diseases · 被引 64)
• Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis (2025 · Nature Communications · 被引 36)
• Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis (2025 · The Lancet Rheumatology · 被引 13)
• Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial (2026 · The Lancet Rheumatology · 被引 11)
• Strengths and limitations of the EULAR definition for difficult-to-treat rheumatoid arthritis (2025 · RMD Open · 被引 9)
• Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease (2025 · Annals of the Rheumatic Diseases · 被引 7)